Global Enzyme Immunoassay (EIA) Reagents and Devices Market, By Technology (Enzyme Immunoassays, Fluorescent Immunoassays, Chemiluminescence, Immunoassays, Radioimmunoassay and Others), Product Type (Analysers and Reagents), Application (Oncology, Infectious diseases, Cardiology, Bone and Mineral, Endocrinology, Autoimmunity, Toxicology, Haematology, Neonatal Screening, and Others), End Users (Hospitals, Laboratories, Academics, Pharmaceutical Industries and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Enzyme Immunoassay (EIA) Reagents and Devices Market
Rising prevalence of chronic and infectious diseases coupled with rising geriatric population are the major reasons attributable to the growth of enzyme immunoassay (EIA) reagents and devices market. Data Bridge Market Research analyses that the enzyme immunoassay (EIA) reagents and devices market will exhibit a CAGR of around 3.63% for the forecast period of 2021-2028.
Enzyme immunoassay (EIA) reagents and devices are used to detect the presence or concentration of an antigen with its application to epidemiological diseases detection. It includes different types of enzymes such as alkaline phosphatases and glucose oxidase. The devices are fragmented on the basis of technology and are used for a wide range of applications such as oncology, endocrinology, autoimmunity, toxicology, haematology, neonatal screening, and others.
Rising prevalence of chronic and infectious diseases is the root cause for the rise in demand for enzyme immunoassay (EIA) reagents and devices. Rising research and developmental proficiencies by the pharmaceutical companies in order to come up with innovative drugs and healthcare technologies are further inducing growth in the demand for enzyme immunoassay (EIA) reagents and devices. Growth and expansion of biotechnological and biopharmaceutical companies is further propelling the market growth.
However, lack of awareness and low detection limits for enzyme immunoassay (EIA) reagents and devices in low and middle class economies will challenge the market growth. Inadequate healthcare technological base in these regions will also derail the market growth rate. Unfavourable reimbursement scenario in developing economies will further restrain the scope of growth for this market.
This enzyme immunoassay (EIA) reagents and devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on enzyme immunoassay (EIA) reagents and devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Enzyme Immunoassay (EIA) Reagents and Devices Market Scope and Market Size
The enzyme immunoassay (EIA) reagents and devices market is segmented on the basis of technology, product type, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of technology, the enzyme immunoassay (EIA) reagents and devices market is segmented into enzyme immunoassays, fluorescent immunoassays, chemiluminescence, immunoassays, radioimmunoassay and others.
- On the basis of product type, the enzyme immunoassay (EIA) reagents and devices market is segmented into analysers and reagents.
- On the basis of application, the enzyme immunoassay (EIA) reagents and devices market is segmented into oncology, infectious diseases, cardiology, bone and mineral, endocrinology, autoimmunity, toxicology, haematology, neonatal screening, and others.
- On the basis of end users, the enzyme immunoassay (EIA) reagents and devices market is segmented into hospitals, laboratories, academics, pharmaceutical industries and others.
Enzyme Immunoassay (EIA) Reagents and Devices Market Country Level Analysis
The enzyme immunoassay (EIA) reagents and devices market is analysed and market size insights and trends are provided by country, technology, product type, application and end users as referenced above.
The countries covered in the enzyme immunoassay (EIA) reagents and devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the enzyme immunoassay (EIA) reagents and devices market is expected to continue its dominant trend during the forecast period. This is because of the increased focus to develop novel drugs and biomarkers for various kinds of diseases. Supportive government funding will also propel the growth of enzyme immunoassay (EIA) reagents and devices market in this region. Asia-Pacific on the other hand will dominate in terms of highest CAGR during the forecast period owing to the increased public and private investment into enzyme immunoassay (EIA) reagents and devices. Rising prevalence of chronic and infectious diseases will further propel the market growth.
The country section of the enzyme immunoassay (EIA) reagents and devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Enzyme immunoassay (EIA) reagents and devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the enzyme immunoassay (EIA) reagents and devices market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Enzyme Immunoassay (EIA) Reagents and Devices Market Share Analysis
The enzyme immunoassay (EIA) reagents and devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to enzyme immunoassay (EIA) reagents and devices market.
The major players covered in the enzyme immunoassay (EIA) reagents and devices market report are Thermo Fisher Scientific Inc., BD, QIAGEN, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Hologic, Inc., Abbott, DSM, DuPont, bioMerieux SA, Promega Corporation., Siemens Healthcare Private Limited, Danaher., Sartorius AG, Sysmex Corporation, Phoenix Pharmaceuticals, DiaSorin S.p.A. and Merck KGaA among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-